A PRELIMINARY STUDY' from this laboratory indicated that the oral administration of neomycin was associated with a significant decrease in serum cholesterol concentration in all of 10 patients. This investigation was prompted by the chance observation that a fall in the level of serum cholesterol occurred in a patient coincident with the oral administration of neomycin, 2 Gm. daily, in the treatment of a gastrointestinal infection due to Salmonella Tennessee. Additional studies are now presented together with experiments designed to clarify the mechanism of action of neomycin in lowering the serum cholesterol level. Evaluation of the effects of other antibiotics on the serum cholesterol levels is also reported.
Method Fifteen male and nine female patients, aged 21 to 72 years, represent the subject material. Twentyone were hospitalized and three were observed as outpatients. The clinical diagnosis of each subject is listed in table 1 Circulation, Volume XXIV, October 1961 with 45 per cent of the calories derived from fat; one (Nas) received a diabetic diet of carbohydrate 180 Gm., protein 80 Gm., fat 80 Gm. without insulin, one (Ber) with familial hypercholesteremia was on a low-fat diet in which 25 per cent of the calories were derived from fat; two (Lew, Les) were maintained on a similar low-fat diet after a preliminary period of 6 weeks on the regular hospital diet. The three outpatients ate an unrestricted and unknown diet during the study.
Average control serum lipid values were established during periods of 4 to 14 weeks (mean 6.7 weeks) prior to administration of the antibiotics. The number of control determinations averaged 12.7 per patient. Oral neomycin was the initial drug studied and was given at the following daily dose level: 0.5 Gm. during five periods, 1 Gm. during five periods, 1.5 Gm. during two periods, 2 Gm. during 15 periods, and 4 Gm. during two periods. The duration of the periods of drug administration varied from 4 to 36 weeks, the mean was 8.5 weeks. In four patients, successive increasing amounts of neomycin were given after 4 to 6 weeks at each dose level without intervening control periods. At the termination of the oral neomycin, a second control period of 5 to 12 weeks was carried out. Many of the subjects were then tested with other oral antibiotics including kanamycin, bacitracin, achromycin, aureomyein, chloromycetin, mycostatin, and streptomycin as well as the following antibiotics given by intramuscular injection: neomycin, streptomycin, and penicillin.* In each instance, a control period of observation preceded the administration of each drug, or each special study when it was desirable to evaluate the effects of a combination of antibiotics.
An alteration of 10 per cent or more from the mean serum cholesterol value of the control period has been found to be necessary to have statistical significance. In a previous report7 from this laboratory, it was shown that the serum cholesterol level in patients with coronary atherosclerosis is inconstant and varies widely. The standard deviation of the mean serum cholesterol values in riod, the drug was given daily in amounts of 2 Gm. for 3 to 5 weeks in seven instances. In two of the drug periods, a significant fall in the serum cholesterol level occurred, averaging 13.5 per cent (table 2 and fig. 2 ). At the 4-Gm. dose level in three trial periods, there was one instance of a significant fall (greater than 10 per cent) in the level of serum cholesterol. Although kanamycin produced a fall in serum cholesterol in 3 of 10 instances, its effect is smaller and less consistent than that of neomycin.
Streptomycin and Bacitracin
The combination of intramuscular streptomycin plus oral bacitracin was thought likely to result in a similar effect as oral neomycin on the bacterial flora of the gastrointestinal tract. One gram of streptomycin (intramuscular) plus 2,500 units of oral bacitracin were given to three patients for 2 weeks after ar initial control period. No significant alteration of the serum cholesterol level occurred. At the end of 2 weeks, 2 Gm. of oral neomycin was added to the streptomycin and bacitracin and in each instance, a significant fall in serum cholesterol level occurred. After 2 weeks of the three medications, the bacitracin and streptomycin were discontinued and the patients continued on the oral neomycin for one additional week. The fall in serum cholesterol level was maintained in each of the three patients (table 3 and fig. 3 ).
Aureomycin
In the previous experiment, when the oral neomycin was stopped, the three patients were transferred to oral aureomycin, 1 Gm. daily for 2 weeks. In one patient, the serum cholesterol level fell further, while in the remaining two patients, the serum cholesterol level increased but did not return to the control level. Additional studies on the effect of aureomycin on the serum cholesterol level are contained in table 4 and figure 4. It can be seen that oral aureomycin (1 Gm. daily for 2 weeks) was prescribed for five periods to four patients. In three of the five periods, a significant fall (greater than 10 per cent) in the serum cholesterol occurred averaging 17 per cent. In two periods, the decrease in serum cholesterol was not significant. Aureomycin had a similar but less marked effect than neomycin on the serum cholesterol level.
Achromycin
Achromycin was administered orally for six periods, 1 Gm. daily for 2 weeks, to four patients. In two instances, the average fall in serum cholesterol level was at borderline significance, while in four periods, the average decrease was less than 10 per cent.
Chloromycetin
Chloromycetin was given orally to three patients at the dose level of 1 Gm. daily for 2 weeks without any significant alteration of the serum cholesterol level. Effect of oral antibiotics on serum cholesterol.
Mycostatin
Oral mycostatin has been administered alone and in conjunction with oral neomycin. Two million units of mycostatin were given for seven periods of 2 weeks to five patients. In three instances, decreases of borderline significance in serum cholesterol level occurred. When mycostatin was given in conjunction with oral neomycin, the same decrease in serum cholesterol concentration occurred as when neomycin alone was given ( fig. 2) . Mycostatin did not appear to potentiate or decrease the effect of neomycin.
Streptomycin
Oral streptomycin (2 Gm. daily) was administered to two patients for 2 weeks without producing an alteration of the level of the serum cholesterol.
Penicillin Intramuscular crystalline penicillin, 1.2 million units daily, was given to three patients for 2 weeks and resulted in no effect on the level of the serum cholesterol.
Discussion
The results presented revealed that oral neomycin consistently produces a significant, sustained fall in the level of serum cholesterol. Of the other antibiotics tested, in a Circulation, Volume Effect of oral antibiotics on serum cholesterol.
limited number of patients, aureomycin and kanamycin resulted in less consistent and less marked decreases in the level of serum cholesterol. Oral achromycin, chloromycetin, bacitracin, streptomycin, mycostatin as well as intramuscular streptomycin, penicillin, and neomycin were ineffective. A number of studies were designed to throw some light on the possible mechanism of action of neomycin. Preliminary studies of bacteriologic content of stools reveal that oral neomycin produces a profound effect upon the intestinal flora. Stool cultures during control periods were compared with those obtained during the neomycin period. Escherichia coli were most effected; with a marked reduction to absence of these organisms from the stool. There is also a suppression of the other enteric organisms except for the enterococei and Clostridium welchii which tend to become more abundant. Further studies of the effect of neomycin upon the intestinal flora are necessary before the mechanism of action of neomycin can be attributed to its bacteriostatic action.
An alteration in the absorption of fat from the gastrointestinal tract has been considered as one of the possible mechanisms of action of neomycin. For this reason, in cooperation with Dr. A. R. Wertheim, oral fat tolerance tests were carried out in eight patients prior to and during the oral administration of neomycin. The test meal consisted of 300 ml. of medium cream (28 per cent fat). In addition 
Experience
In beginning teaching twenty and more years ago, I determined that the basis of what I taught should be that which I myself had seen and proved to be true. A second ideal that I have striven hard to attain is simplicity in teaching; this was not so easy during the years in which my work lay largely amongst pulse and galvanometric curves. But I have become more and more convinced of the need for simplicity; and it was apparent that little of the graphic work could profitably be taught to men entering practice, whose foremost interest must always be in observations they themselves can make upon their patients. 
